Mazdutide 5mg (10 Vials / Kit)

What is Mazdutide?

Mazdutide is engineered from the native oxyntomodulin sequence and modified for extended action, allowing it to engage both the GLP-1 receptor and the glucagon receptor rather than the single-receptor activity of earlier incretin-based peptides.

This listing is Mazdutide (10 vials × 5mg) from TFC Peptides (Tianjin, China), sold on Stairway to Gray with escrow: your payment is held until the order arrives and only then released to the brand.

How it is understood to work

GLP-1 receptor activation is associated with appetite suppression and glucose-dependent insulin release, while glucagon receptor activation is linked to increased energy expenditure and hepatic fat oxidation; combining both is studied as a way to address weight and metabolic-liver endpoints together.

Research status

Mazdutide has progressed through clinical trials for obesity, type 2 diabetes and metabolic dysfunction-associated liver disease, with regulatory status further along in some markets than others. Researchers should verify current approval status for their jurisdiction rather than assume uniform availability.

Specifications

Compound

Mazdutide

Also known as

LY3305677, IBI362

Class

Dual GLP-1 / glucagon receptor agonist

Form

Lyophilized (freeze-dried) powder

Appearance

White lyophilized powder

Per vial

5mg

Units per kit

10

Brand

TFC Peptides · Tianjin, China

Handling & storage

Supplied as a lyophilized powder; store unopened vials at -20 C protected from light, and after reconstitution with bacteriostatic water keep refrigerated and use within the timeframe set by the research protocol.

Concentration check: adding 2 ml of bacteriostatic water to one 5mg vial gives 2.5 mg/ml. The Research Lab calculator in your dashboard works this out for any volume.

Questions

For laboratory research use only. Not for human or veterinary use. Nothing on this page is medical advice.